Concepedia

R. Corre

RC

Statistics

Publications

3

Citations

206

H-Index

3

Active since

2006

Affiliations

Centre Hospitalier de Vitré(Current)

R. Corre is an author at Centre Hospitalier de Vitré specializing in oncology, medicine, and chemotherapy.

Publications per year

2006–2013

3

Publications

3

Erlotinib versus chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations: Interim results of the European Erlotinib Versus Chemotherapy (EURTAC) phase III randomized trial.

R. Rosell, R. Gervais, A. Vergnenègre et al. · Journal of Clinical Oncology · 2011 · 148 citations

Medicine, Oncology, Pharmacology +16

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study

Alexis B. Cortot, L. Gérinière, G. Robinet et al. · Annals of Oncology · 2006 · 47 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study

Olivier Bylicki, Céline Ferlay, C. Chouaïd et al. · Journal of Thoracic Oncology · 2013 · 11 citations

Medicine, Oncology, Pharmacology +12

1–3 of 3